nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CA2—periosteum—sarcoma	0.0156	0.105	CbGeAlD
Dorzolamide—CA5B—mammary gland—sarcoma	0.00808	0.0543	CbGeAlD
Dorzolamide—CA14—seminal vesicle—sarcoma	0.00741	0.0497	CbGeAlD
Dorzolamide—CA5A—liver—sarcoma	0.00658	0.0442	CbGeAlD
Dorzolamide—CA14—cardiac atrium—sarcoma	0.00535	0.0359	CbGeAlD
Dorzolamide—CA12—connective tissue—sarcoma	0.00529	0.0355	CbGeAlD
Dorzolamide—CA5B—hematopoietic system—sarcoma	0.00493	0.0331	CbGeAlD
Dorzolamide—CA9—tendon—sarcoma	0.00491	0.033	CbGeAlD
Dorzolamide—CA14—tendon—sarcoma	0.00466	0.0313	CbGeAlD
Dorzolamide—CA1—hematopoietic system—sarcoma	0.00435	0.0292	CbGeAlD
Dorzolamide—CA9—testis—sarcoma	0.00407	0.0273	CbGeAlD
Dorzolamide—CYP2C9—mammary gland—sarcoma	0.00391	0.0263	CbGeAlD
Dorzolamide—CA5B—cardiac atrium—sarcoma	0.00374	0.0251	CbGeAlD
Dorzolamide—CA14—liver—sarcoma	0.00365	0.0245	CbGeAlD
Dorzolamide—CA4—seminal vesicle—sarcoma	0.00358	0.024	CbGeAlD
Dorzolamide—CA5B—tendon—sarcoma	0.00326	0.0219	CbGeAlD
Dorzolamide—CA2—embryo—sarcoma	0.00316	0.0212	CbGeAlD
Dorzolamide—CA1—lymphoid tissue—sarcoma	0.00306	0.0206	CbGeAlD
Dorzolamide—CA2—seminal vesicle—sarcoma	0.00297	0.0199	CbGeAlD
Dorzolamide—CA2—hematopoietic system—sarcoma	0.00282	0.0189	CbGeAlD
Dorzolamide—CA1—bone marrow—sarcoma	0.00279	0.0187	CbGeAlD
Dorzolamide—CA2—connective tissue—sarcoma	0.00271	0.0182	CbGeAlD
Dorzolamide—CA5B—testis—sarcoma	0.0027	0.0181	CbGeAlD
Dorzolamide—CA4—cardiac atrium—sarcoma	0.00258	0.0173	CbGeAlD
Dorzolamide—CA2—smooth muscle tissue—sarcoma	0.00248	0.0167	CbGeAlD
Dorzolamide—CA2—skin of body—sarcoma	0.00245	0.0165	CbGeAlD
Dorzolamide—CYP2C9—hematopoietic system—sarcoma	0.00239	0.016	CbGeAlD
Dorzolamide—CA1—liver—sarcoma	0.00225	0.0151	CbGeAlD
Dorzolamide—CA4—tendon—sarcoma	0.00225	0.0151	CbGeAlD
Dorzolamide—CA4—bone marrow—sarcoma	0.00218	0.0146	CbGeAlD
Dorzolamide—CA2—cardiac atrium—sarcoma	0.00214	0.0144	CbGeAlD
Dorzolamide—CA2—lymphoid tissue—sarcoma	0.00198	0.0133	CbGeAlD
Dorzolamide—CA5B—lymph node—sarcoma	0.00196	0.0131	CbGeAlD
Dorzolamide—Pain in extremity—Epirubicin—sarcoma	0.00192	0.00225	CcSEcCtD
Dorzolamide—Diplopia—Epirubicin—sarcoma	0.00192	0.00225	CcSEcCtD
Dorzolamide—Feeling abnormal—Dactinomycin—sarcoma	0.00191	0.00225	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Thiotepa—sarcoma	0.00191	0.00225	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dactinomycin—sarcoma	0.0019	0.00223	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00189	0.00222	CcSEcCtD
Dorzolamide—Hypotension—Mitoxantrone—sarcoma	0.00189	0.00222	CcSEcCtD
Dorzolamide—Affect lability—Epirubicin—sarcoma	0.00189	0.00222	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00188	0.00221	CcSEcCtD
Dorzolamide—Insomnia—Vincristine—sarcoma	0.00188	0.00221	CcSEcCtD
Dorzolamide—CA2—tendon—sarcoma	0.00187	0.0125	CbGeAlD
Dorzolamide—Paraesthesia—Vincristine—sarcoma	0.00186	0.00219	CcSEcCtD
Dorzolamide—CA4—testis—sarcoma	0.00186	0.0125	CbGeAlD
Dorzolamide—Urticaria—Thiotepa—sarcoma	0.00186	0.00219	CcSEcCtD
Dorzolamide—Vertigo—Etoposide—sarcoma	0.00185	0.00218	CcSEcCtD
Dorzolamide—Body temperature increased—Thiotepa—sarcoma	0.00185	0.00217	CcSEcCtD
Dorzolamide—Abdominal pain—Thiotepa—sarcoma	0.00185	0.00217	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00184	0.00216	CcSEcCtD
Dorzolamide—Abdominal pain—Dactinomycin—sarcoma	0.00184	0.00216	CcSEcCtD
Dorzolamide—Body temperature increased—Dactinomycin—sarcoma	0.00184	0.00216	CcSEcCtD
Dorzolamide—Cardiac arrest—Epirubicin—sarcoma	0.00182	0.00214	CcSEcCtD
Dorzolamide—CYP3A4—hematopoietic system—sarcoma	0.00182	0.0122	CbGeAlD
Dorzolamide—Cardiac failure—Doxorubicin—sarcoma	0.00182	0.00214	CcSEcCtD
Dorzolamide—Hypoglycaemia—Doxorubicin—sarcoma	0.00182	0.00214	CcSEcCtD
Dorzolamide—Mood swings—Epirubicin—sarcoma	0.00182	0.00213	CcSEcCtD
Dorzolamide—Paraesthesia—Mitoxantrone—sarcoma	0.00182	0.00213	CcSEcCtD
Dorzolamide—Loss of consciousness—Etoposide—sarcoma	0.00181	0.00213	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—sarcoma	0.00181	0.00213	CcSEcCtD
Dorzolamide—CA2—bone marrow—sarcoma	0.00181	0.0121	CbGeAlD
Dorzolamide—Decreased appetite—Vincristine—sarcoma	0.0018	0.00212	CcSEcCtD
Dorzolamide—Dyspnoea—Mitoxantrone—sarcoma	0.0018	0.00212	CcSEcCtD
Dorzolamide—Cough—Etoposide—sarcoma	0.0018	0.00211	CcSEcCtD
Dorzolamide—Somnolence—Mitoxantrone—sarcoma	0.0018	0.00211	CcSEcCtD
Dorzolamide—Fatigue—Vincristine—sarcoma	0.00179	0.0021	CcSEcCtD
Dorzolamide—Dyspepsia—Mitoxantrone—sarcoma	0.00178	0.00209	CcSEcCtD
Dorzolamide—Hypertension—Etoposide—sarcoma	0.00178	0.00209	CcSEcCtD
Dorzolamide—Pain—Vincristine—sarcoma	0.00178	0.00209	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—sarcoma	0.00177	0.00209	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—sarcoma	0.00177	0.00209	CcSEcCtD
Dorzolamide—Decreased appetite—Mitoxantrone—sarcoma	0.00176	0.00206	CcSEcCtD
Dorzolamide—Chest pain—Etoposide—sarcoma	0.00175	0.00206	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—sarcoma	0.00175	0.00205	CcSEcCtD
Dorzolamide—Fatigue—Mitoxantrone—sarcoma	0.00174	0.00205	CcSEcCtD
Dorzolamide—Discomfort—Etoposide—sarcoma	0.00173	0.00204	CcSEcCtD
Dorzolamide—Pain—Mitoxantrone—sarcoma	0.00173	0.00203	CcSEcCtD
Dorzolamide—CA1—lymph node—sarcoma	0.00173	0.0116	CbGeAlD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00173	0.00203	CcSEcCtD
Dorzolamide—Hypersensitivity—Thiotepa—sarcoma	0.00172	0.00203	CcSEcCtD
Dorzolamide—Hypersensitivity—Dactinomycin—sarcoma	0.00171	0.00201	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Vincristine—sarcoma	0.0017	0.00199	CcSEcCtD
Dorzolamide—Confusional state—Etoposide—sarcoma	0.0017	0.00199	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—sarcoma	0.00169	0.00198	CcSEcCtD
Dorzolamide—Anaphylactic shock—Etoposide—sarcoma	0.00168	0.00198	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—sarcoma	0.00168	0.00198	CcSEcCtD
Dorzolamide—Asthenia—Thiotepa—sarcoma	0.00168	0.00197	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—sarcoma	0.00167	0.00196	CcSEcCtD
Dorzolamide—Feeling abnormal—Mitoxantrone—sarcoma	0.00167	0.00196	CcSEcCtD
Dorzolamide—Influenza—Epirubicin—sarcoma	0.00166	0.00195	CcSEcCtD
Dorzolamide—Pruritus—Thiotepa—sarcoma	0.00166	0.00195	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00165	0.00194	CcSEcCtD
Dorzolamide—Body temperature increased—Vincristine—sarcoma	0.00164	0.00193	CcSEcCtD
Dorzolamide—Abdominal pain—Vincristine—sarcoma	0.00164	0.00193	CcSEcCtD
Dorzolamide—Hyperhidrosis—Etoposide—sarcoma	0.00163	0.00191	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—sarcoma	0.00161	0.0019	CcSEcCtD
Dorzolamide—Urticaria—Mitoxantrone—sarcoma	0.00161	0.00189	CcSEcCtD
Dorzolamide—Anorexia—Etoposide—sarcoma	0.0016	0.00188	CcSEcCtD
Dorzolamide—Diarrhoea—Thiotepa—sarcoma	0.0016	0.00188	CcSEcCtD
Dorzolamide—Body temperature increased—Mitoxantrone—sarcoma	0.0016	0.00188	CcSEcCtD
Dorzolamide—Abdominal pain—Mitoxantrone—sarcoma	0.0016	0.00188	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.0016	0.00188	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—sarcoma	0.00159	0.00187	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—sarcoma	0.00159	0.00187	CcSEcCtD
Dorzolamide—Hypotension—Etoposide—sarcoma	0.00157	0.00185	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—sarcoma	0.00155	0.00182	CcSEcCtD
Dorzolamide—Dizziness—Thiotepa—sarcoma	0.00155	0.00182	CcSEcCtD
Dorzolamide—CA2—testis—sarcoma	0.00154	0.0104	CbGeAlD
Dorzolamide—Upper respiratory tract infection—Epirubicin—sarcoma	0.00154	0.00181	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—sarcoma	0.00153	0.0018	CcSEcCtD
Dorzolamide—Hypersensitivity—Vincristine—sarcoma	0.00153	0.0018	CcSEcCtD
Dorzolamide—Paraesthesia—Etoposide—sarcoma	0.00151	0.00177	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—sarcoma	0.0015	0.00176	CcSEcCtD
Dorzolamide—Dyspnoea—Etoposide—sarcoma	0.0015	0.00176	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—sarcoma	0.0015	0.00176	CcSEcCtD
Dorzolamide—Somnolence—Etoposide—sarcoma	0.00149	0.00176	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—sarcoma	0.00149	0.00176	CcSEcCtD
Dorzolamide—Hypersensitivity—Mitoxantrone—sarcoma	0.00149	0.00175	CcSEcCtD
Dorzolamide—Asthenia—Vincristine—sarcoma	0.00149	0.00175	CcSEcCtD
Dorzolamide—Vomiting—Thiotepa—sarcoma	0.00149	0.00175	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—sarcoma	0.00148	0.00174	CcSEcCtD
Dorzolamide—Rash—Thiotepa—sarcoma	0.00148	0.00173	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—sarcoma	0.00147	0.00173	CcSEcCtD
Dorzolamide—Dermatitis—Thiotepa—sarcoma	0.00147	0.00173	CcSEcCtD
Dorzolamide—Headache—Thiotepa—sarcoma	0.00147	0.00172	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00147	0.00172	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—sarcoma	0.00146	0.00172	CcSEcCtD
Dorzolamide—Decreased appetite—Etoposide—sarcoma	0.00146	0.00172	CcSEcCtD
Dorzolamide—CA2—liver—sarcoma	0.00146	0.00981	CbGeAlD
Dorzolamide—Asthenia—Mitoxantrone—sarcoma	0.00145	0.0017	CcSEcCtD
Dorzolamide—Fatigue—Etoposide—sarcoma	0.00145	0.0017	CcSEcCtD
Dorzolamide—Pain—Etoposide—sarcoma	0.00144	0.00169	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—sarcoma	0.00144	0.00169	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—sarcoma	0.00144	0.00169	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—sarcoma	0.00143	0.00169	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00143	0.00167	CcSEcCtD
Dorzolamide—Diarrhoea—Vincristine—sarcoma	0.00142	0.00167	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—sarcoma	0.00142	0.00166	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—sarcoma	0.00139	0.00164	CcSEcCtD
Dorzolamide—Nausea—Thiotepa—sarcoma	0.00139	0.00163	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—sarcoma	0.00139	0.00163	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—sarcoma	0.00139	0.00163	CcSEcCtD
Dorzolamide—Feeling abnormal—Etoposide—sarcoma	0.00139	0.00163	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—sarcoma	0.00138	0.00163	CcSEcCtD
Dorzolamide—Diarrhoea—Mitoxantrone—sarcoma	0.00138	0.00163	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—sarcoma	0.00138	0.00162	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—sarcoma	0.00138	0.00162	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Etoposide—sarcoma	0.00138	0.00162	CcSEcCtD
Dorzolamide—Dizziness—Vincristine—sarcoma	0.00137	0.00161	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00136	0.00159	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—sarcoma	0.00135	0.00159	CcSEcCtD
Dorzolamide—CA4—lymph node—sarcoma	0.00135	0.00907	CbGeAlD
Dorzolamide—Urticaria—Etoposide—sarcoma	0.00134	0.00157	CcSEcCtD
Dorzolamide—Abdominal pain—Etoposide—sarcoma	0.00133	0.00156	CcSEcCtD
Dorzolamide—Body temperature increased—Etoposide—sarcoma	0.00133	0.00156	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—sarcoma	0.00133	0.00156	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—sarcoma	0.00133	0.00156	CcSEcCtD
Dorzolamide—Vomiting—Vincristine—sarcoma	0.00132	0.00155	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—sarcoma	0.00132	0.00155	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—sarcoma	0.00131	0.00154	CcSEcCtD
Dorzolamide—Rash—Vincristine—sarcoma	0.00131	0.00154	CcSEcCtD
Dorzolamide—Dermatitis—Vincristine—sarcoma	0.00131	0.00154	CcSEcCtD
Dorzolamide—Headache—Vincristine—sarcoma	0.0013	0.00153	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—sarcoma	0.00129	0.00152	CcSEcCtD
Dorzolamide—Vomiting—Mitoxantrone—sarcoma	0.00129	0.00151	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—sarcoma	0.00128	0.00151	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—sarcoma	0.00128	0.0015	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—sarcoma	0.00128	0.0015	CcSEcCtD
Dorzolamide—Rash—Mitoxantrone—sarcoma	0.00127	0.0015	CcSEcCtD
Dorzolamide—Dermatitis—Mitoxantrone—sarcoma	0.00127	0.0015	CcSEcCtD
Dorzolamide—Headache—Mitoxantrone—sarcoma	0.00127	0.00149	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—sarcoma	0.00125	0.00147	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—sarcoma	0.00125	0.00147	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—sarcoma	0.00124	0.00146	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—sarcoma	0.00124	0.00145	CcSEcCtD
Dorzolamide—CYP2C9—liver—sarcoma	0.00124	0.0083	CbGeAlD
Dorzolamide—Nausea—Vincristine—sarcoma	0.00123	0.00145	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—sarcoma	0.00122	0.00143	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—sarcoma	0.00121	0.00142	CcSEcCtD
Dorzolamide—Nausea—Mitoxantrone—sarcoma	0.0012	0.00141	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—sarcoma	0.00119	0.0014	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—sarcoma	0.00119	0.00139	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—sarcoma	0.00118	0.00139	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—sarcoma	0.00117	0.00138	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—sarcoma	0.00116	0.00136	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—sarcoma	0.00115	0.00136	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—sarcoma	0.00115	0.00135	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—sarcoma	0.00114	0.00134	CcSEcCtD
Dorzolamide—Tension—Epirubicin—sarcoma	0.00113	0.00133	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—sarcoma	0.00113	0.00133	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—sarcoma	0.00112	0.00132	CcSEcCtD
Dorzolamide—CA2—lymph node—sarcoma	0.00112	0.00752	CbGeAlD
Dorzolamide—Back pain—Epirubicin—sarcoma	0.00112	0.00131	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—sarcoma	0.00111	0.00131	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—sarcoma	0.0011	0.00129	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—sarcoma	0.00109	0.00128	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—sarcoma	0.00108	0.00127	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—sarcoma	0.00107	0.00126	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—sarcoma	0.00107	0.00126	CcSEcCtD
Dorzolamide—Rash—Etoposide—sarcoma	0.00106	0.00125	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—sarcoma	0.00106	0.00124	CcSEcCtD
Dorzolamide—Headache—Etoposide—sarcoma	0.00105	0.00124	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—sarcoma	0.00105	0.00123	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—sarcoma	0.00105	0.00123	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—sarcoma	0.00104	0.00122	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—sarcoma	0.00104	0.00122	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—sarcoma	0.00104	0.00122	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—sarcoma	0.00103	0.00121	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—sarcoma	0.00102	0.0012	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—sarcoma	0.00102	0.00119	CcSEcCtD
Dorzolamide—Cough—Epirubicin—sarcoma	0.00101	0.00118	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—sarcoma	0.00101	0.00118	CcSEcCtD
Dorzolamide—Nausea—Etoposide—sarcoma	0.000999	0.00117	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—sarcoma	0.000997	0.00117	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—sarcoma	0.000983	0.00116	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—sarcoma	0.000983	0.00116	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—sarcoma	0.00098	0.00115	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—sarcoma	0.000972	0.00114	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—sarcoma	0.000962	0.00113	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—sarcoma	0.00096	0.00113	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—sarcoma	0.000958	0.00113	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—sarcoma	0.00095	0.00112	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—sarcoma	0.000944	0.00111	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—sarcoma	0.000943	0.00111	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—sarcoma	0.000943	0.00111	CcSEcCtD
Dorzolamide—CYP3A4—liver—sarcoma	0.000942	0.00633	CbGeAlD
Dorzolamide—Loss of consciousness—Doxorubicin—sarcoma	0.000939	0.0011	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—sarcoma	0.000933	0.0011	CcSEcCtD
Dorzolamide—Shock—Epirubicin—sarcoma	0.000927	0.00109	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—sarcoma	0.000923	0.00108	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—sarcoma	0.000911	0.00107	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—sarcoma	0.00091	0.00107	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—sarcoma	0.00091	0.00107	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—sarcoma	0.000907	0.00107	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—sarcoma	0.000899	0.00106	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—sarcoma	0.000899	0.00106	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—sarcoma	0.00089	0.00105	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—sarcoma	0.000881	0.00103	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—sarcoma	0.000879	0.00103	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—sarcoma	0.000872	0.00102	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—sarcoma	0.000872	0.00102	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000859	0.00101	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—sarcoma	0.000858	0.00101	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—sarcoma	0.000853	0.001	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—sarcoma	0.000846	0.000995	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—sarcoma	0.000843	0.000991	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—sarcoma	0.00084	0.000987	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—sarcoma	0.000838	0.000985	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—sarcoma	0.000831	0.000977	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—sarcoma	0.00083	0.000975	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—sarcoma	0.000819	0.000963	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—sarcoma	0.000815	0.000958	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—sarcoma	0.000813	0.000955	CcSEcCtD
Dorzolamide—Pain—Epirubicin—sarcoma	0.000806	0.000947	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000795	0.000934	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—sarcoma	0.000789	0.000927	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—sarcoma	0.000783	0.00092	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—sarcoma	0.000778	0.000914	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—sarcoma	0.000777	0.000913	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—sarcoma	0.000775	0.000911	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000771	0.000906	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—sarcoma	0.000768	0.000902	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—sarcoma	0.000758	0.000891	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—sarcoma	0.000752	0.000884	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—sarcoma	0.000749	0.00088	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—sarcoma	0.000746	0.000876	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—sarcoma	0.000745	0.000876	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—sarcoma	0.000745	0.000876	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—sarcoma	0.000719	0.000844	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000713	0.000838	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—sarcoma	0.000694	0.000816	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—sarcoma	0.000693	0.000814	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—sarcoma	0.000689	0.00081	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—sarcoma	0.000689	0.00081	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—sarcoma	0.000676	0.000795	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—sarcoma	0.000667	0.000784	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—sarcoma	0.000645	0.000758	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—sarcoma	0.000643	0.000755	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—sarcoma	0.000626	0.000735	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—sarcoma	0.000623	0.000732	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—sarcoma	0.000617	0.000725	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—sarcoma	0.000599	0.000704	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—sarcoma	0.000597	0.000701	CcSEcCtD
Dorzolamide—Rash—Epirubicin—sarcoma	0.000594	0.000698	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—sarcoma	0.000594	0.000698	CcSEcCtD
Dorzolamide—Headache—Epirubicin—sarcoma	0.000591	0.000694	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—sarcoma	0.000577	0.000678	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—sarcoma	0.00056	0.000658	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—sarcoma	0.000555	0.000652	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—sarcoma	0.00055	0.000646	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—sarcoma	0.000549	0.000646	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—sarcoma	0.000546	0.000642	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—sarcoma	0.000518	0.000609	CcSEcCtD
